Ipsen specializes in the research, development, manufacturing and marketing of medications. Sales break down by family of products as follows:
- specialty drugs (89.3%). Sales break down by therapeutic area between oncology (80.2%), neuroscience (17%) and rare diseases (2.8%);
- consumer healthcare products (10.7%): products used in the treatment of gastrointestinal disorders, neurodegenerative pathologies and rheumatological disorders.
At the end of 2019, the group had 8 research and development centres located in France (2), the United Kingdom (2), the United States, Germany, Ireland and China, and 8 production sites worldwide.
Sales are distributed geographically as follows: France (12.5%), Germany (7.3%), Italy (4.5%), Spain (4.1%), the United Kingdom (4.1%), Europe (19.4%), North America (30.1%), Asia (8.9%) and other (9.1%).